Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126603732 | 12660373 | 2 | F | 20160829 | 20160817 | 20160902 | EXP | PHHY2016BR106614 | NOVARTIS | 0.00 | F | Y | 78.00000 | KG | 20160902 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126603732 | 12660373 | 1 | PS | DIOVAN | VALSARTAN | 1 | Oral | 1 DF, QD | 1602760 | 21283 | 1 | DF | TABLET | QD | |||||
| 126603732 | 12660373 | 2 | SS | DIOVAN | VALSARTAN | 1 | Oral | 2 DF, QD | 1602760 | 21283 | 2 | DF | TABLET | QD | |||||
| 126603732 | 12660373 | 3 | SS | DIOVAN | VALSARTAN | 1 | Oral | 1 DF, QD | 1602760 | 21283 | 1 | DF | TABLET | QD | |||||
| 126603732 | 12660373 | 4 | SS | DIOVAN | VALSARTAN | 1 | Oral | 1 DF, BID (1 TABLET IN THE MORNING AND 1 TABLET AT NIGHT) | 1602760 | 21283 | 1 | DF | TABLET | BID | |||||
| 126603732 | 12660373 | 5 | SS | APRESOLIN | HYDRALAZINE HYDROCHLORIDE | 1 | Oral | 2 DF, QD | Y | 0 | 2 | DF | TABLET | QD | |||||
| 126603732 | 12660373 | 6 | SS | APRESOLIN | HYDRALAZINE HYDROCHLORIDE | 1 | Oral | 1 DF, QD | Y | 0 | 1 | DF | TABLET | QD | |||||
| 126603732 | 12660373 | 7 | SS | APRESOLIN | HYDRALAZINE HYDROCHLORIDE | 1 | Oral | 2 DF, QD | Y | 0 | 2 | DF | TABLET | QD | |||||
| 126603732 | 12660373 | 8 | C | FRONTAL | ALPRAZOLAM | 1 | Unknown | 2 DF QD | 0 | 2 | DF | TABLET | QD | ||||||
| 126603732 | 12660373 | 9 | C | FRONTAL | ALPRAZOLAM | 1 | 0 | TABLET | |||||||||||
| 126603732 | 12660373 | 10 | C | HIDROCLOROTIAZIDA | HYDROCHLOROTHIAZIDE | 1 | Oral | 1 DF, QD | 0 | 1 | DF | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126603732 | 12660373 | 1 | Hypertension |
| 126603732 | 12660373 | 5 | Hypertension |
| 126603732 | 12660373 | 8 | Panic disorder |
| 126603732 | 12660373 | 9 | Anxiety |
| 126603732 | 12660373 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126603732 | 12660373 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126603732 | 12660373 | Abdominal pain upper | |
| 126603732 | 12660373 | Blood pressure decreased | |
| 126603732 | 12660373 | Blood pressure inadequately controlled | |
| 126603732 | 12660373 | Chest pain | |
| 126603732 | 12660373 | Dry mouth | |
| 126603732 | 12660373 | Gastrointestinal disorder | |
| 126603732 | 12660373 | Hypertension | |
| 126603732 | 12660373 | Hypotonia | |
| 126603732 | 12660373 | Liver disorder | |
| 126603732 | 12660373 | Malaise | |
| 126603732 | 12660373 | Myalgia | |
| 126603732 | 12660373 | Peripheral swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |